$0.078
-0.005[-6.02%]
Last update: 3:50PM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
| Open0.084 | Close0.078 |
| Vol / Avg.1.350K / 41.809K | Mkt Cap6.587M |
| Day Range0.078 - 0.084 | 52 Wk Range0.075 - 0.210 |
Hemostemix Stock (OTC:HMTXF), Key Statistics
Hemostemix Stock (OTC: HMTXF) analysis, key statistics.
Valuation Measures
Enterprise Value
10.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-39.89%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-0.06
Tangible Book value per share
-0.06
Total Liabilities (Quarterly)
7.2M
Total Assets
305.1K
Total Liabilities
7.2M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Hemostemix Stock (OTC:HMTXF), Key Statistics
Hemostemix Stock (OTC: HMTXF) analysis, key statistics.
Valuation Measures
Enterprise Value
10.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-39.89%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-0.06
Tangible Book value per share
-0.06
Total Liabilities (Quarterly)
7.2M
Total Assets
305.1K
Total Liabilities
7.2M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Hemostemix Stock (OTC:HMTXF), Key Statistics
Hemostemix Stock (OTC: HMTXF) analysis, key statistics.
Valuation Measures
Enterprise Value
10.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-39.89%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-0.06
Tangible Book value per share
-0.06
Total Liabilities (Quarterly)
7.2M
Total Assets
305.1K
Total Liabilities
7.2M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Hemostemix Stock (OTC:HMTXF), Key Statistics
Hemostemix Stock (OTC: HMTXF) analysis, key statistics.
Valuation Measures
Enterprise Value
10.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-39.89%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-0.06
Tangible Book value per share
-0.06
Total Liabilities (Quarterly)
7.2M
Total Assets
305.1K
Total Liabilities
7.2M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Hemostemix Stock (OTC:HMTXF), Key Statistics
Hemostemix Stock (OTC: HMTXF) analysis, key statistics.
Valuation Measures
Enterprise Value
10.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-39.89%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-0.06
Tangible Book value per share
-0.06
Total Liabilities (Quarterly)
7.2M
Total Assets
305.1K
Total Liabilities
7.2M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Hemostemix Stock (OTC:HMTXF), Key Statistics
Hemostemix Stock (OTC: HMTXF) analysis, key statistics.
Valuation Measures
Enterprise Value
10.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-39.89%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-0.06
Tangible Book value per share
-0.06
Total Liabilities (Quarterly)
7.2M
Total Assets
305.1K
Total Liabilities
7.2M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Hemostemix Stock (OTC:HMTXF), Key Statistics
Hemostemix Stock (OTC: HMTXF) analysis, key statistics.
Valuation Measures
Enterprise Value
10.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-39.89%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-0.06
Tangible Book value per share
-0.06
Total Liabilities (Quarterly)
7.2M
Total Assets
305.1K
Total Liabilities
7.2M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Hemostemix Stock (OTC:HMTXF), Key Statistics
Hemostemix Stock (OTC: HMTXF) analysis, key statistics.
Valuation Measures
Enterprise Value
10.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-39.89%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-0.06
Tangible Book value per share
-0.06
Total Liabilities (Quarterly)
7.2M
Total Assets
305.1K
Total Liabilities
7.2M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Hemostemix Stock (OTC:HMTXF), Key Statistics
Hemostemix Stock (OTC: HMTXF) analysis, key statistics.
Valuation Measures
Enterprise Value
10.4M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
- -
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-39.89%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
-0.06
Tangible Book value per share
-0.06
Total Liabilities (Quarterly)
7.2M
Total Assets
305.1K
Total Liabilities
7.2M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -